Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease.
about
Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases.A prospective single centre pilot evaluation of a serum calprotectin assay in unselected GI patients.Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease.Identification of Pathway-Specific Serum Biomarkers of Response to Glucocorticoid and Infliximab Treatment in Children with Inflammatory Bowel Disease.Monitoring of small bowel Crohn's disease.Medical versus surgical management of penetrating Crohn's disease: the current situation and future perspectives.Optimizing pharmacologic management of inflammatory bowel disease.Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials.Endoscopic evaluation in diagnosis and management of inflammatory bowel disease.Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn's Disease: Results from the EXTEND Trial.A Low Neutrophil CD64 Index Is Associated with Sustained Remission During Infliximab Maintenance Therapy.Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease.The Lewis score or the capsule endoscopy Crohn's disease activity index: which one is better for the assessment of small bowel inflammation in established Crohn's disease?Re: American Gastroenterological Association Institute Guideline on therapeutic drug monitoring in inflammatory bowel disease.Enteral Nutrition in the Management of Crohn's Disease: Reviewing Mechanisms of Actions and Highlighting Potential Venues for Enhancing the Efficacy.An update on diagnostic and prognostic biomarkers in inflammatory bowel disease.Changing nationwide trends in endoscopic, medical and surgical admissions for inflammatory bowel disease: 2003-2013.Vedolizumab for inflammatory bowel disease: From randomized controlled trials to real-life evidence.Treat-to-target in Crohn's disease: Will transmural healing become a therapeutic endpoint?From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting
P2860
Q30249313-D95B503F-43D1-4684-9FB2-EF5BA0978797Q33824685-0BCA3BBA-AE1B-402E-862F-AB16CB15460CQ37273489-15ED041F-C195-4004-8FCE-D804B5E054C4Q37620348-DA764F7D-EEED-4D22-8D59-ED216484F758Q38652740-F9695A21-4FFE-4DF6-A5DE-544E173FB432Q38668874-0481316D-7BA3-4184-A931-6C2DCEDE30FCQ38687407-080EF446-95DE-4881-BB74-1B04662EFD90Q38888227-F18BFBBB-23DE-4980-9B00-66F516B51282Q39064412-5DAC3812-6A1C-4D2E-AF92-05FEDB58AA80Q39213809-6AB67801-DECC-44E9-BDE4-D13962E2DE1DQ42759481-2E9B33B6-7697-4773-AF72-4636F65CA445Q45937561-295F311F-CFA5-456C-958F-DA2B42F27327Q48109444-F58A8CD2-90CE-443C-9FC9-40691B791FD0Q49193405-859DE83E-E91C-4C9E-9D45-784415589671Q50092863-61AF3F68-D524-467A-9546-4873CF52BC2FQ53128510-919AB19B-9B94-4B1D-A69F-D2D31FE40282Q53833375-93E87479-6454-465D-A650-E3C5D6EADC5FQ55316690-26F9C73C-AC83-46BC-9F4C-55650D0601CDQ58551550-847876D9-9169-46DC-9549-6DBB8293852FQ58760402-908F0264-B845-4FC1-AA24-61E4BC7580A9
P2860
Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Systematic review with meta-an ...... m outcomes in Crohn's disease.
@en
type
label
Systematic review with meta-an ...... m outcomes in Crohn's disease.
@en
prefLabel
Systematic review with meta-an ...... m outcomes in Crohn's disease.
@en
P2093
P2860
P356
P1476
Systematic review with meta-an ...... m outcomes in Crohn's disease.
@en
P2093
P2860
P304
P356
10.1111/APT.13475
P407
P577
2015-11-25T00:00:00Z